Double Blind, Safety and Immunogenicity Study of Recombinant Botulinum Vaccine A/B
about
Double Blind, Safety and Immunogenicity Study of Recombinant Botulinum Vaccine A/B
description
clinical trial
@en
klinisch onderzoek
@nl
name
Double Blind, Safety and Immunogenicity Study of Recombinant Botulinum Vaccine A/B
@en
Double Blind, Safety and Immunogenicity Study of Recombinant Botulinum Vaccine A/B
@nl
type
label
Double Blind, Safety and Immunogenicity Study of Recombinant Botulinum Vaccine A/B
@en
Double Blind, Safety and Immunogenicity Study of Recombinant Botulinum Vaccine A/B
@nl
prefLabel
Double Blind, Safety and Immunogenicity Study of Recombinant Botulinum Vaccine A/B
@en
Double Blind, Safety and Immunogenicity Study of Recombinant Botulinum Vaccine A/B
@nl
P1050
P1476
A Phase 2, Randomized, Double ...... rBV A/B-40, in Healthy Adults
@en
P3098
NCT00764634
P580
2008-09-01T00:00:00Z
P582
2010-03-01T00:00:00Z